This study aims to retrospectively analyze the clinicopathological characteristics, traditional MRI features, and radiomics features of HR+/HER2- cancer BC patients to identify features independently associated with tumor shrinkage patterns post-NAC and establish a predictive model. Here, ERBB2 is linked to breast cancer.